Mishra Gauravi A, Pimple Sharmila A, Shastri Surendra S
Department of Preventive Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Indian J Med Paediatr Oncol. 2011 Jul;32(3):125-32. doi: 10.4103/0971-5851.92808.
Cervical cancer still remains the most common cancer affecting the Indian women. India alone contributes 25.41% and 26.48% of the global burden of cervical cancer cases and mortality, respectively. Ironically, unlike most other cancers, cervical cancer can be prevented through screening by identifying and treating the precancerous lesions, any time during the course of its long natural history, thus preventing the potential progression to cervical carcinoma. Several screening methods, both traditional and newer technologies, are available to screen women for cervical precancers and cancers. No screening test is perfect and hence the choice of screening test will depend on the setting where it is to be used. Similarly, various methods are available for treatment of cervical precancers and the selection will depend on the cost, morbidity, requirement of reliable biopsy specimens, resources available, etc. The recommendations of screening for cervical cancer in the Indian scenario are discussed.
宫颈癌仍然是影响印度女性的最常见癌症。仅印度就分别占全球宫颈癌病例负担和死亡率的25.41%和26.48%。具有讽刺意味的是，与大多数其他癌症不同，宫颈癌可以通过筛查来预防，即在其漫长的自然病程中的任何时候识别并治疗癌前病变，从而防止其发展为宫颈癌。有几种筛查方法，包括传统方法和新技术，可用于筛查女性的宫颈前癌和癌症。没有一种筛查测试是完美的，因此筛查测试的选择将取决于其使用的环境。同样，有多种方法可用于治疗宫颈前癌，选择将取决于成本、发病率、可靠活检标本的需求、可用资源等。本文讨论了印度宫颈癌筛查的建议。
